INVO Bioscience, Inc. (INVO) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Devices 行业. 公司总部位于 Sarasota, FL, 美国. 现任CEO为 Steven M. Shum.
INVO 拥有 IPO日期为 2020-11-02, 25 名全职员工, 在 NASDAQ Capital Marke, 市值为 $3.25M.
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
